Published in Women's Health Weekly, March 24th, 2011
"Archival tissue specimens from 99 patients with primary invasive breast cancer were selected. The cortactin expression was analyzed by TMA. Age, estrogen receptor status, histological grading and TNM staging data were also collected. There were 23 patients (23.2%) with low (+) expression of cortactin, 60 patients (60.6%)...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly